Proto Labs PRLB 深 沪
等待开盘 11-04 09:30:00 美东时间
53.47
+3.710
+7.46%
华盛通- 最 高53.52
- 今 开49.91
- 成交量 61.24万股
- 最 低 47.84
- 昨 收 49.76
- 总市值 12.77亿
- 52周最高 55.90
- 市盈率 静 81.25
- 换手率 2.57%
- 52周最低 29.585
- 委 比 69.49%
- 总股本 2387.48万
- 历史最高 286.57
- 量 比 2.23
- 振 幅 11.41%
- 历史最低 22.04
- 每 手 1
- 风险率 5.53%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Benchmark Maintains Buy on Proto Labs, Raises Price Target to $55
Benchmark analyst Robert Wasserman maintains Proto Labs (NYSE:PRLB) with a Buy and raises the price target from $45 to $55.
11-03 21:54
电话会总结 ｜ Proto Labs(PRLB)2025财年Q3业绩电话会核心要点
<span style="color:#999999;">编者按：聚焦公司高管观点与展望，深挖业绩背后的信息，助力投资者把握先机。</span><blockquote><p><span style="color:#fa1432;"><strong>业绩回顾</strong></span></p></blockquote><p>• 根据Proto Labs业绩会实录，以下是财务业绩回顾摘要： ## 1. 财务业绩 **营收表现：** - Q3 2025营收达到1.354亿美元，同比增长7.8%，创季度历史新高 - 按固定汇率计算同比增长6.8% - 美国市场营收同比增长10%，欧洲市场营收按固定汇率计算下降5% **分业务营收：** - CNC加工营收同比增长18.2%（固定汇率增长17%），美国CNC加工营收同比增长24% - 钣金加工营收同比增长13.9%（固定汇率增长13.3%） - 注塑成型营收同比增长2%（固定汇率增长1.2%） - 3D打印营收同比下降6.3%（固定
11-03 12:07
Earnings Scheduled For October 31, 2025
Companies Reporting Before The Bell • T. Rowe Price Group (NASDAQ:TROW) is esti...
10-31 19:11
Proto Labs Sees Q4 GAAP EPS $0.12-$0.20 vs $0.18 Est
Proto Labs (NYSE:PRLB) is looking for Q4 GAAP EPS of $0.12-$0.20 vs $0.18 analyst estimate..
10-31 18:01
Proto Labs Q3 Adj. EPS $0.47 Beats $0.39 Estimate, Sales $135.366M Beat $133.833M Estimate
Proto Labs (NYSE:PRLB) reported quarterly earnings of $0.47 per share which beat the analyst consensus estimate of $0.39 by 19.9 percent. This is unchanged from the same period last year. The company reported quarterly
10-31 18:00
Protolabs Introduces Advanced Features For Its Automated CNC Machining Service, Enabling Engineers And Product Developers To Access High-Quality Metal And Plastic Parts With Tighter Tolerances, Diverse Finishes, And Fast, Comprehensive Quality Documentation
Protolabs has announced the launch of advanced features within its automated CNC machining service, designed to empower engineers and product developers with reliable, high-quality milled parts at speed.The expanded
10-16 21:07
ProPhase Labs Inc. to Participate in Renmark’s Virtual Non-Deal Roadshow Series on Thursday, September 4, 2025
ProPhase Labs Inc. will participate in Renmark Financial Communications' virtual non-deal roadshow on September 4, 2025, to discuss its investor presentation, which includes updates on its crypto treasury strategy, potential liquidity events, and the cancellation of the Equity Line of Credit (ELOC). Investors can register for the live event or access the replay post-event via the provided link. The event will feature Ted Karkus, the company's Cha...
09-03 12:00
ProPhase Labs Announces Full USPTO Approval for Issuance of U.S. Patent Protecting Esophageal Adenocarcinoma Risk Assessment
ProPhase Labs, Inc. has been granted U.S. Patent No. 12379378-B2 for its biomarker-based systems and methods to assess progression risk in Barrett’s esophagus and esophageal adenocarcinoma. This follows the successful validation of its BE-Smart™ molecular diagnostic, achieving over 95% technical success and compatibility with both brush and forceps biopsies, enhancing early detection. The patent, developed by inventors Joe Abdo, Sumeet K. Mittal,...
08-12 12:00
Proto Labs shares are trading higher after the company reported better-than-expected Q2 financial results and issued Q3 sales guidance above estimates.
Proto Labs shares are trading higher after the company reported better-than-exp...
07-31 20:57
Proto Labs Sees Q3 Adj EPS $0.35-$0.43 vs $0.37 Est; Sees Sales $130M-$138M vs $129.652M Est; Sees Q3 GAAP EPS $0.17-$0.25 vs $0.20 Est
Third Quarter 2025 OutlookIn the third quarter of 2025, the Company expects to generate revenue between $130.0 million and $138.0 million.The Company expects third quarter 2025 diluted net income per share between $0.17
07-31 18:02
